peptide hormones
Showing 1 - 25 of 4,180
Obesity, Cardiovascular Physiological Phenomena, Metabolism Trial in Nashville (recombinant human BNP (1-32), normal saline ())
Active, not recruiting
- Obesity
- +2 more
- recombinant human BNP (1-32)
- normal saline (placebo)
-
Nashville, Tennessee
- +1 more
Mar 23, 2022
Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)
Recruiting
- Blood Flow
- GIPR antagonist / study tool
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Nov 2, 2022
Pancreatectomy; Hyperglycemia Trial in Hellerup (Intravenous infusion)
Not yet recruiting
- Pancreatectomy; Hyperglycemia
- Intravenous infusion
-
Hellerup, DenmarkClinical Metabolic Physiology
Dec 14, 2021
Obesity, Appetitive Behavior Trial in La Plata (food (breakfast))
Completed
- Obesity
- Appetitive Behavior
- food (breakfast)
-
La Plata, Buenos Aires, ArgentinaInstituto de Desarrollo e Investigaciones Pediátricas (IDIP)
Apr 4, 2023
Endocrine Hormones to Hypoglycemia in Type 1 or Type 2 Diabetes
Completed
- Diabetes
- The hyperinsulinaemic hypoglycaemic clamp
-
Nanjing, ChinaNanjing First Hospital, Nanjing Medical Univesity
Oct 10, 2022
Obesity, Overweight Trial in Peshawar (High Protein Meal at Cold Temperature, High Protein Meal at Warm Temperarute, High
Recruiting
- Obesity, Overweight
- High Protein Meal at Cold Temperature
- +8 more
-
Peshawar, KPK, PakistanKhyber Medical University
Apr 7, 2023
Obesity Trial in Hellerup (LEAP-2 Protein, Human)
Recruiting
- Obesity
- LEAP-2 Protein, Human
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Oct 31, 2022
Metabolism Disorder, Nutrition Trial in Nanjing (Macronutrients, Mixed meal tolerance test (MMTT))
Not yet recruiting
- Metabolism Disorder
- Nutrition
- Macronutrients
- Mixed meal tolerance test (MMTT)
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital, Nanjing Medical University
Mar 13, 2023
Impaired Cardiac Function in Patients With Diabetes Mellitus
Recruiting
- Diabetes Mellitus
- Left Ventricular Dysfunction
- Assessment of cardiovascular risk factor, endocrine hormones and related biomarker
-
Nanjing, Jiangsu, ChinaThe affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 2, 2022
Obesity Trial (Ileal Interposition, Traditional surgical technique)
Not yet recruiting
- Obesity
- Ileal Interposition
- Traditional surgical technique
- (no location specified)
Jul 8, 2023
Obesity, Diabetes, Type 2 Trial in Toronto (Dairy and plant-based dairy beverages and solids)
Completed
- Obesity
- Diabetes Mellitus, Type 2
- Dairy and plant-based dairy beverages and solids
-
Toronto, Ontario, CanadaDepartment of Nutritional Sciences, C. David Naylor Building
Jun 22, 2023
Whether Osteocrin Levels Are Associated With Glycemic Control, Vascular Disorders in Diabetic Patients Trial in Assiut
Recruiting
- Whether Osteocrin Levels Are Associated With Glycemic Control, Vascular Disorders in Diabetic Patients
- osteocrin
-
Assiut, Egyptwalaa soliman Hussien
Jan 31, 2023
Digestive Health, Gastrointestinal Health, Appetitive Behavior Trial in Montréal (OPTIZIOME® P³ HYDROLYZER® - WHEY, Placebo)
Not yet recruiting
- Digestive Health
- +2 more
- OPTIZIOME® P³ HYDROLYZER® - WHEY
- Placebo
-
Montréal, Quebec, CanadaMcGill University, Currie Gymnasium (Exercise Metabolism and Nut
Jul 21, 2023
Hypertension, Hypertension, Essential Trial in Nashville (Angiotensin (1-7), Trimethaphan, Phenylephrine)
Active, not recruiting
- Hypertension
- Hypertension, Essential
- Angiotensin (1-7)
- +2 more
-
Nashville, TennesseeVanderbilt University
Jan 2, 2023
Healthy Trial in Glasgow (Bouts of Exercise)
Not yet recruiting
- Healthy
- Bouts of Exercise
-
Glasgow, United KingdomNew Lister Building at Glasgow Royal Infirmary
Oct 19, 2023
Healthy, Type 1 Diabetes Trial in Tartu (Placebo, Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector)
Not yet recruiting
- Healthy
- Type 1 Diabetes
- Placebo
- Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector
-
Tartu, EstoniaTartu University Hospital
Apr 7, 2023
Cardiovascular Diseases Trial in Leiden (Mixed meal test)
Recruiting
- Cardiovascular Diseases
- Mixed meal test
-
Leiden, NetherlandsLeiden University Medical Center
Apr 12, 2023
Diabetes, Cardiovascular Diseases, Insulin Sensitivity/Resistance Trial in Birmingham (drug, other, dietary supplement)
Recruiting
- Diabetes Mellitus
- +6 more
- Sacubitril, Valsartan 97-103 mg Oral Tablet
- +4 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 15, 2022
Gastroparesis With Diabetes Trial in Hvidovre (G-POEM, Sham)
Recruiting
- Gastroparesis With Diabetes Mellitus
- G-POEM
- Sham
-
Hvidovre, Region Hovedstaden, DenmarkMelina Svraka Hansen
Apr 25, 2023
Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone
Active, not recruiting
- Obesity
-
Nottingham, Notts, United KingdomQueens Medical Centre
Apr 5, 2022
Energy Intake, Gastrointestinal Hormones, Glycemic Control Trial in Basel (Xylitol, Sucrose, Acesulfame Potassium)
Not yet recruiting
- Energy Intake
- +4 more
- Xylitol
- +3 more
-
Basel, SwitzerlandSt. Claraspital
Dec 20, 2022
Heart Diseases, Left Ventricular Dysfunction Trial in Arlington (Estradiol patch, Cetrotide, Fasting)
Recruiting
- Heart Diseases
- Left Ventricular Dysfunction
- Estradiol patch
- +3 more
-
Arlington, TexasUniversity of Texas at Arlington
Mar 10, 2022
Endocrine Changes in Adults Undergoing Cardiac Surgery
Active, not recruiting
- Endocrine System Diseases
- +3 more
-
Budapest, Hungary
- +2 more
Jan 7, 2022
Natriuretic Peptides, Obesity, Nocturnal Blood Pressure Trial in Birmingham (standardized Study Diet)
Completed
- Natriuretic Peptides
- +2 more
- standardized Study Diet
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 14, 2022